๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Non-small Cell Lung Cancer Stage IIIB

Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation NCT05010109NA1 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: 6 Minute Walk Functional Test, Biospecimen Collection, Computed Tomography, Echocardiography, Exercise Cardiac Stress Tโ€ฆ Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung) NCT07120698Phase 22 sites๐Ÿ“ Guangzhou๐Ÿ“ Chengdu Guangdong Association of Clinical Trials ยท Tests: Sintilimab Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC) NCT07153445Phase 221 sites๐Ÿ“ Alicante๐Ÿ“ Badalona๐Ÿ“ Barcelona Fundaciรณn GECP ยท Tests: Atezolizumab, Paclitaxel, Carboplatin A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) NCT05920356Phase 3424 sites๐Ÿ“ Santa Barbara๐Ÿ“ Newark๐Ÿ“ Coral Springs Amgen ยท Tests: Sotorasib, Pembrolizumab A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) NCT06312137Phase 3270 sites๐Ÿ“ Little Rock๐Ÿ“ Springdale๐Ÿ“ Beverly Hills Merck Sharp & Dohme LLC ยท Tests: Sacituzumab tirumotecan, Pembrolizumab, Cisplatin, Pemetrexed, Gemcitabine Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial NCT07288034Phase 213 sites๐Ÿ“ Goodyear๐Ÿ“ Corona๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Adagrasib, Anti-PD-L1 Monoclonal Antibody, Anti-PD1 Monoclonal Antibody, Bevacizumab, Biopsy Procedure Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient NCT07198217Phase 21 site๐Ÿ“ Zibo Zibo Municipal Hospital ยท Tests: SBRT combined with Tislelizumab followed by Tislelizumab Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations NCT07195695Phase 3202 sites๐Ÿ“ Fresno๐Ÿ“ Glendale๐Ÿ“ Orange Boehringer Ingelheim ยท Tests: Zongertinib, Pembrolizumab, Atezolizumab, Durvalumab, Nivolumab Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression NCT06269211Phase 22 sites๐Ÿ“ Guangzhou๐Ÿ“ Shanghai Ruijin Hospital ยท Tests: Toripalimab MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC NCT05286957Phase 21 site๐Ÿ“ Zhengzhou The First Affiliated Hospital of Zhengzhou University ยท Tests: adjuvant tislelizumab and chemotherapy for MRD+ patients, adjuvant tislelizumab and chemotherapy for MRD+ patients, adjโ€ฆ Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer๏ผšA Prospective, Single-Arm, Phase II Study NCT07085182Phase 21 site๐Ÿ“ Zibo Zibo Municipal Hospital ยท Tests: SBRT combined with Tislelizumab followed by Tislelizumab Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung Cancer NCT07855965Phase 29 sites๐Ÿ“ Chengdu๐Ÿ“ Chengdu๐Ÿ“ Chengdu West China Hospital ยท Tests: Cryo-Thermal Ablation, Toripalimab, Platinum-based doublet chemotherapy Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) NCT04267848Phase 31151 sites๐Ÿ“ Anchorage๐Ÿ“ Anchorage๐Ÿ“ Anchorage National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Carboplatin, Cisplatin, Computed Tomography, Echocardiography Test Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer NCT06659042Phase 21 site๐Ÿ“ Shanghai Shanghai Chest Hospital ยท Tests: Tislelizumab, Cisplatin, Carboplatin, Pemetrexed Disodium Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial NCT06096844Phase 3328 sites๐Ÿ“ Fayetteville๐Ÿ“ Fort Smith๐Ÿ“ Rogers National Cancer Institute (NCI) ยท Tests: Carboplatin, Computed Tomography, Magnetic Resonance Imaging, Nab-paclitaxel, Paclitaxel Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC NCT04865250Phase 21 site๐Ÿ“ Heidelberg University Hospital Heidelberg ยท Tests: Atezolizumab 1200 mg abs day 1 q22 (iv) Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer NCT03819296Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Best Practice, Biospecimen Collection, Endoscopic Procedure, Fecal Microbiota Transplantation, Infliximab A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer. NCT06284317Phase 342 sites๐Ÿ“ Camperdown๐Ÿ“ Penrith๐Ÿ“ St Leonards ETOP IBCSG Partners Foundation ยท Tests: Adjuvant durvalumab Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC NCT06532591Phase 21 site๐Ÿ“ Chengdu Sichuan Cancer Hospital and Research Institute ยท Tests: cadonilimab+paclitaxel/albumin-bound paclitaxel+carboplatin Alectinib Pharmacokinetic in Patients With NSCLC NCT05713006Phase 1, Phase 21 site๐Ÿ“ Mexico City Instituto Nacional de Cancerologia de Mexico ยท Tests: Alectinib Oral Product Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC NCT06864624Phase 23 sites๐Ÿ“ Changsha๐Ÿ“ Yinchuan๐Ÿ“ Xi'an Tang-Du Hospital ยท Tests: Sunvozertinib A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) NCT07154290Phase 218 sites๐Ÿ“ Birmingham๐Ÿ“ Goodyear๐Ÿ“ Irvine Regeneron Pharmaceuticals ยท Tests: Ubamatamab, Marlotamig, Sarilumab Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC NCT07003490NA2 sites๐Ÿ“ Shanghai๐Ÿ“ Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Scโ€ฆ ยท Tests: Radical Resection with Bilateral Lymph Node Dissection Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. NCT06167460n/a1 site๐Ÿ“ Ho Chi Minh City Gene Solutions Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer NCT06918132Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biospecimen Collection, Cemiplimab, Fianlimab, Magnetic Resonance Imaging, Surgical Procedure MK-3475AยฑCalderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013) NCT07431827Phase 3117 sites๐Ÿ“ Ciudad Autรณnoma de Buenos Aires๐Ÿ“ Rosario๐Ÿ“ CABA Merck Sharp & Dohme LLC ยท Tests: Calderasib, MK-3475A, Placebo Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC NCT07309952Phase 21 site๐Ÿ“ Guangzhou Yang Hong ยท Tests: Sintilimab, Paclitaxel, Carboplatin (AUC 5), Pemetrexed 500 mg/m2, Stereotactic body radiotherapy (SBRT) Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations NCT06041776Phase 33 sites๐Ÿ“ Beijing๐Ÿ“ Nanjing๐Ÿ“ Shanghai Betta Pharmaceuticals Co., Ltd. ยท Tests: Befotertinib + Icotinib placebo, Icotinib + Befotertinib placebo Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy NCT07039656Phase 21 site๐Ÿ“ Guangzhou Wen-zhao ZHONG ยท Tests: Toripalimab, Cisplatin-based chemotherapy EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients NCT07096258n/a4 sites๐Ÿ“ Nancy๐Ÿ“ Naples๐Ÿ“ Madrid Hedera Dx SA
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy